Risk Management Plan: Expert Review of Applications for Marketing Authorisation in the EAEU Depending on the Type of Medicinal Product (Review)
INTRODUCTION. A risk management plan (RMP) is an important document for assessing and managing risks when using a medicinal product. An RMP is provided as part of the marketing authorisation application for a medicinal product. The requirements for the need to submit an RMP and the information in it...
Saved in:
Main Authors: | T. M. Bukatina (Author), E. V. Shubnikova (Author) |
---|---|
Format: | Book |
Published: |
Ministry of Health of the Russian Federation, Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products»,
2024-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Risk Management Plan: An Expert Analysis of Changes to the EAEU Good Pharmacovigilance Practice Requirements for the Content and Submission of the Document
by: T. M. Bukatina, et al.
Published: (2023) -
Applied Research Conference "Expert examination and registration of medicines in the EAEU" (RegLek - EAEU 2021)
by: article Editorial
Published: (2021) -
Critical Overview of the Contents of Risk Management Plans for Medicines
by: T. M. Bukatina, et al.
Published: (2022) -
Authorisation for Fusafungine-Containing Medicines is Revoked
by: Z. A. Alacheva
Published: (2016) -
New Technologies in Electronic Pharmacovigilance Systems for Marketing Authorisation Holders
by: O. A. Loginovskaya, et al.
Published: (2022)